1178-6930
Yes
ONCOTARGETS THER
2008
585
ENGLAND
https://www.dovepress.com/oncotargets-and-therapy-journal
较慢,6-12周审稿时间
3区中科院分区
较易平均录用比例
2.8影响因子
生物工程与应用微生物小学科
160/326JIF RANK
14107总被引频次
一份国际性的同行评审期刊,聚焦于所有癌症的病理基础、治疗的潜在目标和用于改善癌症患者管理的治疗方案。该杂志还关注管理方案、新的治疗剂和治疗方案对患者生活质量、依从性和满意度等方面的影响。这本杂志探讨了新疗法和现有疗法在改善结果方面的证据,并且,重要的是,将寻求根据患者和医疗保健专业人员的最终吸收和接受来定义它们的用法。
https://www.dovepress.com/submit_step_1.php
An international, peer-reviewed journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal also focuses on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 4区 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ONCOLOGY 肿瘤学 | 3区 4区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q2 | ONCOLOGY | Q2 | 4.345 |
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Q2 |
CiteScore | SJR | SNIP | 学科类别 | 分区 | 排名 | 百分位 |
7.00 | 0.811 | 0.812 | 大类:Medicine 小类:Pharmacology (medical) | Q1 | 37 / 255 |
85% |
大类:Medicine 小类:Oncology | Q1 | 80 / 360 |
77% |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
4.345 | 44 | 97.03% | 84.15% | 开放 | 较慢,6-12周 |